PubRank
Search
About
Mark Minden
Author PubWeight™ 46.13
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia.
J Clin Oncol
2012
5.75
2
The genomic landscape of hypodiploid acute lymphoblastic leukemia.
Nat Genet
2013
3.43
3
PPM1D mutations in circulating white blood cells and the risk for ovarian cancer.
J Natl Cancer Inst
2013
3.15
4
Phase 1 study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in leukemia.
Blood
2008
2.04
5
A randomized phase I clinical and biologic study of two schedules of sorafenib in patients with myelodysplastic syndrome or acute myeloid leukemia: a NCIC (National Cancer Institute of Canada) Clinical Trials Group Study.
Leuk Lymphoma
2010
1.79
6
PML/RARalpha targets promoter regions containing PU.1 consensus and RARE half sites in acute promyelocytic leukemia.
Cancer Cell
2010
1.75
7
Low-dose prophylactic platelet transfusions in recipients of an autologous peripheral blood progenitor cell transplant and patients with acute leukemia: a randomized controlled trial with a sequential Bayesian design.
Transfusion
2004
1.69
8
A Pan-BCL2 inhibitor renders bone-marrow-resident human leukemia stem cells sensitive to tyrosine kinase inhibition.
Cell Stem Cell
2013
1.59
9
Nuclear localizing sequences promote nuclear translocation and enhance the radiotoxicity of the anti-CD33 monoclonal antibody HuM195 labeled with 111In in human myeloid leukemia cells.
J Nucl Med
2006
1.58
10
Abducted by the illness: a qualitative study of traumatic stress in individuals with acute leukemia.
Leuk Res
2013
1.56
11
Altered DNA methylation in leukocytes with trisomy 21.
PLoS Genet
2010
1.44
12
The study of epigenetic mechanisms based on the analysis of histone modification patterns by flow cytometry.
Cytometry A
2013
1.43
13
ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia.
Proc Natl Acad Sci U S A
2012
1.25
14
A single nucleotide polymorphism chip-based method for combined genetic and epigenetic profiling: validation in decitabine therapy and tumor/normal comparisons.
Cancer Res
2006
1.17
15
Synergistic effect of inhibiting translation initiation in combination with cytotoxic agents in acute myelogenous leukemia cells.
Leuk Res
2009
1.09
16
Molecular cytogenetic characterization of non-Hodgkin lymphoma cell lines.
Genes Chromosomes Cancer
2002
1.08
17
Nonmyeloablative stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemia in patients 60 years or older.
Biol Blood Marrow Transplant
2005
1.07
18
PPARα and fatty acid oxidation mediate glucocorticoid resistance in chronic lymphocytic leukemia.
Blood
2013
1.03
19
Gene expression profiles in acute myeloid leukemia with common translocations using SAGE.
Proc Natl Acad Sci U S A
2006
1.01
20
Getting results for hematology patients through access to the electronic health record.
Can Oncol Nurs J
2006
0.99
21
Preferential eradication of acute myelogenous leukemia stem cells by fenretinide.
Proc Natl Acad Sci U S A
2013
0.92
22
Local radiotherapy induces homing of hematopoietic stem cells to the irradiated bone marrow.
Cancer Res
2007
0.91
23
Auger electron radioimmunotherapeutic agent specific for the CD123+/CD131- phenotype of the leukemia stem cell population.
J Nucl Med
2011
0.87
24
Finding new bearings: a qualitative study on the transition from inpatient to ambulatory care of patients with acute myeloid leukemia.
Support Care Cancer
2014
0.86
25
Disease biology rather than age is the most important determinant of survival of patients > or = 60 years with acute myeloid leukemia treated with uniform intensive therapy.
Cancer
2005
0.85
26
Similar outcomes of cryopreserved allogeneic peripheral stem cell transplants (PBSCT) compared to fresh allografts.
Biol Blood Marrow Transplant
2007
0.84
27
The oncogene PDGF-B provides a key switch from cell death to survival induced by TNF.
Oncogene
2005
0.84
28
Sensitivity of myeloid leukemia cells to calcium influx blockade: application to bone marrow purging.
Exp Hematol
2002
0.84
29
Fungal liver infection in immunocompromised patients: depiction with multiphasic contrast-enhanced helical CT.
Radiology
2005
0.84
30
Decitabine in acute myeloid leukemia.
Semin Hematol
2005
0.82
31
Clinical efficacy of prophylactic strategy of long-term low-dose acyclovir for Varicella-Zoster virus infection after allogeneic peripheral blood stem cell transplantation.
Clin Transplant
2008
0.81
32
Chest low-dose computed tomography in neutropenic acute myeloid leukaemia patients.
Respir Med
2009
0.81
33
miR-126 Regulates Distinct Self-Renewal Outcomes in Normal and Malignant Hematopoietic Stem Cells.
Cancer Cell
2016
0.80
34
Cryptic insertion of MLL gene into 9p22 leads to MLL-MLLT3 (AF9) fusion in a case of acute myelogenous leukemia.
Genes Chromosomes Cancer
2004
0.77
35
The effect of local breast radiotherapy on circulating CD34(+) cells.
Radiother Oncol
2011
0.75